Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Milestones
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept amrx:MilestonesExpense.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s affordable medicines — milestones.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s affordable medicines — milestones?
- Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — milestones of $500K in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s affordable medicines — milestones changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s affordable medicines — milestones increased by 100.0% year-over-year, from $250K to $500K.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s affordable medicines — milestones?
- Over 2 years (2022 to 2024), Amneal Pharmaceuticals, Inc.'s affordable medicines — milestones has grown at a 144.9% compound annual growth rate (CAGR), from $6.41M to $38.48M.
- What does affordable medicines — milestones mean?
- Captures payments made or received upon the achievement of specific development, regulatory, or commercial milestones in pharmaceutical partnerships. These payments are indicative of progress in the product lifecycle and collaborative agreements.